نتائج البحث - "Malou C.P. Kuppen"

1

Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands

المؤلفون: Winald R. Gerritsen, A.C.M. van den Bergh, Inge M. van Oort, Ronald de Wit, Carin A. Uyl-de Groot, Andre M. Bergman, Malou C.P. Kuppen, Reindert J.A. van Moorselaar, Hans M. Westgeest, Jules Lavalaye, Metin Tascilar, Alfons J.M. van den Eertwegh, Diederik M. Somford, Niven Mehra, Katja K.H. Aben

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical Oncology, Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Urology

المصدر: Clinical genitourinary cancer, 20(1), 43-52. CIG MEDIA GROUP, LP
Clinical Genitourinary Cancer, 20(1), 43-52. Elsevier
Clinical Genitourinary Cancer, 20, 43-52
Clinical Genitourinary Cancer, 20, 1, pp. 43-52
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Tascilar, M, Mehra, N, Lavalaye, J, Somford, D M, Aben, K K H, Bergman, A M, de Wit, R, van den Bergh, A C M, de Groot, C A U & Gerritsen, W R 2022, ' Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population : Results From the CAPRI-Study in the Netherlands ', Clinical Genitourinary Cancer, vol. 20, no. 1, pp. 43-52 . https://doi.org/10.1016/j.clgc.2021.10.008Test

مصطلحات موضوعية: Male, Bisphophonates, medicine.medical_specialty, Pathologic fracture, Urology, Population, Butylated Hydroxyanisole, Bone Neoplasms, Castration resistant, Skeletal related events, Bone health, Prostate cancer, SDG 3 - Good Health and Well-being, Spinal cord compression, Bone Density, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Medicine, Humans, education, Netherlands, Real-world evidence, education.field_of_study, business.industry, Bone metastases, Life-prolonging drugs, medicine.disease, Prostatic Neoplasms, Castration-Resistant, Denosumab, Oncology, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Orthopedic surgery, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d177b59c6e2b3659b939a21de276f6Test
https://research.rug.nl/en/publications/6aff08ca-2583-4fbf-80f0-7e6b97065874Test

2

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands

المساهمون: Health Technology Assessment (HTA), Medical Oncology, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical oncology, CCA - Cancer Treatment and quality of life

المصدر: Clinical Genitourinary Cancer, 17, 5, pp. e946-e956
Clinical Genitourinary Cancer, 17(5), E946-E956. Elsevier
Clinical genitourinary cancer, 17(5), E946-E956. CIG MEDIA GROUP, LP
Westgeest, H M, Kuppen, M C P, van den Eertwegh, A J M, de Wit, R, Coenen, J L L M, van den Berg, H P, Mehra, N, van Oort, I M, Fossion, L M C L, Hendriks, M P, Bloemendal, H J, van de Luijtgaarden, A C M, ten Bokkel Huinink, D, van den Bergh, A C M, van den Bosch, J, Polee, M B, Weijl, N, Bergman, A M, Uyl-de Groot, C A & Gerritsen, W R 2019, ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands ', Clinical Genitourinary Cancer, vol. 17, no. 5, pp. e946-e956 . https://doi.org/10.1016/j.clgc.2019.05.018Test
Clinical Genitourinary Cancer, 17(5), e946-e956. Elsevier
Clinical Genitourinary Cancer, 17, e946-e956

مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, 030232 urology & nephrology, PLUS PREDNISONE, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Neoplasm Metastasis, Netherlands, DOCETAXEL, Clinical Trials as Topic, education.field_of_study, CYCLES, Abiraterone acetate, Standard of Care, MEN, Middle Aged, CHEMOTHERAPY, Prognosis, OPEN-LABEL, ABIRATERONE ACETATE, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Docetaxel, Cabazitaxel, SAFETY, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], 030220 oncology & carcinogenesis, POSTDOCETAXEL, Taxoids, medicine.drug, Registry, medicine.medical_specialty, Urology, Population, INCREASED SURVIVAL, Antineoplastic Agents, 03 medical and health sciences, Trial eligibility, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Humans, Real-world outcomes, education, Aged, Retrospective Studies, Chemotherapy, L-Lactate Dehydrogenase, business.industry, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Trial population, Clinical trial, chemistry, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55db3d2d7c2abd92a4b76a9b4278c5eTest
https://doi.org/10.1016/j.clgc.2019.05.018Test

3

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life, Internal medicine

المصدر: European urology oncology, 4(4), 618-627. De Tijdstroom/Elsevier
European Urology Oncology, 4, 618-627
European urology oncology, 4, 618-627. Elsevier
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, ' Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Oncology, vol. 4, no. 4, pp. 618-627 . https://doi.org/10.1016/j.euo.2019.09.005Test
European Urology Oncology, 4, 4, pp. 618-627
European Urology Oncology, 4(4), 618-627. Elsevier BV

مصطلحات موضوعية: Oncology, Male, ANTITUMOR-ACTIVITY, 030232 urology & nephrology, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Prednisone, Medicine, Sequencing, Registries, Castration-resistant prostate cancer, DOCETAXEL, Abiraterone acetate, TIME, Prostatic Neoplasms, Castration-Resistant, TRIALS, Docetaxel, Pharmaceutical Preparations, Cabazitaxel, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Androgens, Cross resistance, medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, ENZALUTAMIDE, Urology, INCREASED SURVIVAL, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antigen, SDG 3 - Good Health and Well-being, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Enzalutamide, Humans, Radiology, Nuclear Medicine and imaging, Real-world outcomes, Retrospective Studies, Androgen-receptor targeting agents, business.industry, Androgen Antagonists, medicine.disease, Androgen receptor, chemistry, Surgery, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5688ade1d20f2f2f131d73a057ff810Test
https://research.rug.nl/en/publications/41b16b5e-d8f6-46e7-904f-77d48f068028Test

4

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry

المؤلفون: Alphons C.M. van den Bergh, Hans M. Westgeest, Walter L. Vervenne, Niven Mehra, Diederik M. Somford, Jules L.L.M. Coenen, Inge M. van Oort, Alfons J.M. van den Eertwegh, Malou C.P. Kuppen, Reindert J.A. van Moorselaar, Jessica Notohardjo, Carin A. Uyl-de Groot, Winald R. Gerritsen, Aad I. de Vos, Katja K.H. Aben, Andries M. Bergman

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Health Technology Assessment (HTA), Medical oncology, Urology, CCA - Cancer Treatment and quality of life

المصدر: European Urology Focus, 7, 4, pp. 788-796
European Urology Focus, 7(4), 788-796. De Tijdstroom/Elsevier
Notohardjo, J C L, Kuppen, M C P, Westgeest, H M, van Moorselaar, R J A, Mehra, N, Coenen, J L L M, van Oort, I M, de Vos, A I, Vervenne, W L, van den Bergh, A C M, Aben, K K H, Somford, D M, Bergman, A M, Uyl-de Groot, C A, Gerritsen, W R & van den Eertwegh, A J M 2021, ' Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population : Results from the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 7, no. 4, pp. 788-796 . https://doi.org/10.1016/j.euf.2020.03.009Test
European Urology Focus. Elsevier
European Urology Focus, 7, 788-796
European Urology Focus, 7(4), 788-796. Elsevier BV

مصطلحات موضوعية: Male, Oncology, PREDNISONE, medicine.medical_specialty, ENZALUTAMIDE, Urology, ANTITUMOR-ACTIVITY, Population, 030232 urology & nephrology, Life-prolonging drug, Castration resistant, 03 medical and health sciences, Drug treatment, Prostate cancer, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, hemic and lymphatic diseases, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Real-world outcomes, Prospective Studies, Registries, education, Retrospective Studies, Castration-resistant prostate cancer, DOCETAXEL, education.field_of_study, business.industry, Real world outcomes, Third line, CHEMOTHERAPY, Prognosis, medicine.disease, PROGNOSTIC MODEL, MITOXANTRONE, Clinical Practice, ABIRATERONE ACETATE, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, CABAZITAXEL, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Prognostic model, SURVIVAL, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863af5bcaa0e4492253e7fa5bfd10a57Test
https://repository.ubn.ru.nl/handle/2066/237201Test

5

Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry

المؤلفون: Niven Mehra, Jules Lavalaye, W R Gerritsen, Malou C.P. Kuppen, H.M. Westgeest, J. Van Moorselaar, D.M. Somford, F. Van Den Eertwegh, F. Van Den Bergh, Andre M. Bergman, Katja K.H. Aben, Jules L.L.M. Coenen, C.A. Uyl-de Groot

المصدر: European Urology Supplements. 17:e2891-e2893

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Urology, Anti-Androgen, Castration resistant, medicine.disease, chemistry.chemical_compound, Prostate cancer, chemistry, Internal medicine, Medicine, Enzalutamide, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2d121ee6d702e44bf827f95033cf8e78Test
https://doi.org/10.1016/s1569-9056Test(18)33756-4

6

Patient Safety Risks of Basic Urological Procedures Performed by Junior and Senior Residents

المؤلفون: Evert L. Koldewijn, Rob C.M. Pelger, Malou C.P. Kuppen, Barbara M.A. Schout, Anna H. de Vries, Cordula Wagner, Maaike C. Boute, Jeroen J. G. van Merriënboer

المساهمون: Public and occupational health, EMGO - Quality of care, Onderwijsontw & Onderwijsresearch, RS: SHE - R1 - Research (OvO), Family Medicine

المصدر: Journal of Surgical Education, 72(5), 918-926. Elsevier Inc.
de Vries, A H, Boute, M C, Kuppen, M C P, Van Merrienboer, J J G, Koldewijn, E L, Pelger, R C M, Schout, B M A & Wagner, C 2015, ' Patient Safety Risks of Basic Urological Procedures Performed by Junior and Senior Residents ', Journal of Surgical Education, vol. 72, no. 5, pp. 918-926 . https://doi.org/10.1016/j.jsurg.2015.04.014Test